To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
844 Current news from the ressort financesrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...
Swiss start-up Qnami closes 2.6M CHF seed round
Qnami announced the closing of a CHF 2.6M (USD 2.6M) seed round led by Venture Capital fund Quantonation and further supported by investiere, ZKB Start-up Finance and the High-Tech Gründerfonds. The funds will support the market entry of Qnami’s first product, a quantum microscope for inspection ...
Realignment of organometallics business
Specialty chemicals company LANXESS performed well again in the third quarter of 2019 – despite further deterioration of the economic environment. As expected, earnings in the third quarter were only slightly weaker than in the previous year. At EUR267 million, EBITDA pre exceptionals was 3.6 ...
Difficult macroeconomic environment impacts adversely on operating activities again
Brenntag achieved stable results in the third quarter of 2019 that were once again impacted by the difficult macroeconomic conditions. Particularly in the two large Brenntag regions EMEA and North America, the economic environment continued to turn down. Asia Pacific delivered good quarterly ...
Stricter cost discipline supports earnings
Evonik is sticking to its full-year earnings outlook despite an ongoing weakness in the global economy. The company expects adjusted EBITDA to remain at least stable compared with last year. Sales are now expected to be slightly lower than the previous year because of lower demand. Evonik had ...
Clariant announced nine months 2019 continuing operations sales of CHF3.272billion compared to CHF3.278billion in the first nine months of 2018. This corresponds to an organic growth of 3% in local currency and a stable development in Swiss francs. Both higher volumes and pricing contributed ...
Agreements signed to divest Currenta and Animal Health
Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales ...
New circular economy program launched
In the third quarter of 2019 Covestro was able to achieve core volume growth of 5.3% over the prior-year period in a continuing challenging economic environment. At the same time, Group sales declined as expected by 14.6% to EUR 3.2 billion due to continued lower selling prices. At EUR 425 ...
Evonik Venture Capital has invested in an Israeli software start-up that helps industrial companies adopt 3D printing. Castor Technologies has developed a software that assesses a part’s printability, the best printing material, cost and lead time. The technology helps manufacturers decide if and ...
In Q3 2019, Wacker Chemie AG grew sales year over year and, due to special income, also its EBITDA. Reporting-quarter sales at the Munich chemical group came in at €1,267.9 million (Q3 2018: €1,242.7 million). That was a gain of 2 percent. This growth was fueled chiefly by positive volume and ...